Trending

Aridis Receives FDA Feedback on Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design May 31, 2023

Remark AI Awarded $6 million Rio De Janeiro police contract May 31, 2023

Adamas One Acquires Minority Equity Stake in NexGenAI Solutions Group May 31, 2023

LL Flooring Receives Unsolicited Buyout Offer May 31, 2023

Marker Therapeutics Reports Positive MT-601 Pre-Clinical Data May 31, 2023

Next

Prev

$403.13 $7.90 2.00%

$180.09 $2.84 1.60%

$122.77 $2.19 1.82%

$207.52 $3.59 1.76%

$124.37 $1.00 0.81%

Market Movers

Chubb Names Paul Johnstone President of Canadian Operations; John Alfieri to Retire after Nearly Two Decades of Service

by 24/7 MarketNews

May 6, 2022 at 11:50 AM

WHITEHOUSE STATION, N.J., May 6, 2022 /PRNewswire/ — Chubb today announced that Paul Johnstone will assume the role of Country President of the company’s business operations in Canada, subject to regulatory approvals. Currently, Mr. Johnstone serves as Chief Operating Officer in Canada….

Read the entire article here.

RelatedNews

Equitable Announces Election Of Directors

Advisor Group Continues To Grow and Build On Its Strategic Vision With Addition Of Experienced Business Strategist and Compliance Expert

Chubb Names Paul Johnstone President of Canadian Operations; John Alfieri to Retire after Nearly Two Decades of Service

Harbour BioMed Appoints Dr. Alexander A. Zukiwski to its Scientific Advisory Board

Ovintiv Announces Results of Annual Meeting

Want more news like this? Check out our homepage!

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recent News

Connect Biopharma Higher on Positive Phase 2 Icanbelimod Trial Data

June 2, 2023

Monopar Reports Positive Camsirubicin Phase 1b Trial Update

June 1, 2023

U Power Limited Forms Strategic Cooperation Agreement with Quantum Solutions

June 1, 2023

Wearable Devices Begins Manufacturing Mudra Bands for Apple Watch

June 1, 2023

Aridis Receives FDA Feedback on Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design

May 31, 2023

Follow Us

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.

Search by keyword

© 2022-2023 24/7MarketNews – The Experts in Investor and Public Relations